You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE

Citation Tools

Article menu

Download PDFPDF

Oral Presentations
New treatments in SLE, Sjögren's and APS
OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Wallace D, Ginzler E, Merrill J, et al
OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE
Annals of the Rheumatic Diseases 2017;76:150-151.